Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi-Mi Wu

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Cancer Research Communications|June 28, 2023
Optimizing Precision Medicine for Breast Cancer Brain Metastases with Functional Drug Response AssessmentAki Morikawa, Jinju Li, Peter Ulintz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2017
Gene Copy Number Estimation from Targeted Next-Generation Sequencing of Prostate Cancer Biopsies: Analytic Validation and Clinical QualificationGeorge Seed, Wei Yuan, Joaquin Mateo, et al.
Nature Genetics|January 20, 2015
The landscape of long noncoding RNAs in the human transcriptomeMatthew K Iyer, Yashar S Niknafs, Rohit Malik, et al.
Molecular Cell|November 20, 2012
Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancerIrfan A Asangani, Bushra Ateeq, Qi Cao, et al.
Cell|June 16, 2018
Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate CancerYi-Mi Wu, Marcin Cieślik, Robert J Lonigro, et al.
Cancer Research|August 5, 2015
The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell CarcinomaPaul William Harms, Pankaj Vats, Monique Elise Verhaegen, et al.
Nature Genetics|January 15, 2013
Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencingDan R Robinson, Yi-Mi Wu, Shanker Kalyana-Sundaram, et al.
Nature Communications|June 29, 2022
The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myelomaJosh N Vo, Yi-Mi Wu, Jeanmarie Mishler, et al.
Cancer Cell|August 16, 2011
Coordinated regulation of polycomb group complexes through microRNAs in cancerQi Cao, Ram-Shankar Mani, Bushra Ateeq, et al.
Oncotarget|June 15, 2018
Clinical validation of the Tempus xO assayNike Beaubier, Robert Tell, Robert Huether, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Cancer Research Communications|June 28, 2023
Optimizing Precision Medicine for Breast Cancer Brain Metastases with Functional Drug Response AssessmentAki Morikawa, Jinju Li, Peter Ulintz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2017
Gene Copy Number Estimation from Targeted Next-Generation Sequencing of Prostate Cancer Biopsies: Analytic Validation and Clinical QualificationGeorge Seed, Wei Yuan, Joaquin Mateo, et al.
Nature Genetics|January 20, 2015
The landscape of long noncoding RNAs in the human transcriptomeMatthew K Iyer, Yashar S Niknafs, Rohit Malik, et al.
Molecular Cell|November 20, 2012
Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancerIrfan A Asangani, Bushra Ateeq, Qi Cao, et al.
Cell|June 16, 2018
Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate CancerYi-Mi Wu, Marcin Cieślik, Robert J Lonigro, et al.
Cancer Research|August 5, 2015
The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell CarcinomaPaul William Harms, Pankaj Vats, Monique Elise Verhaegen, et al.
Nature Genetics|January 15, 2013
Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencingDan R Robinson, Yi-Mi Wu, Shanker Kalyana-Sundaram, et al.
Nature Communications|June 29, 2022
The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myelomaJosh N Vo, Yi-Mi Wu, Jeanmarie Mishler, et al.
Cancer Cell|August 16, 2011
Coordinated regulation of polycomb group complexes through microRNAs in cancerQi Cao, Ram-Shankar Mani, Bushra Ateeq, et al.
Oncotarget|June 15, 2018
Clinical validation of the Tempus xO assayNike Beaubier, Robert Tell, Robert Huether, et al.
Pageof 8